Nircef capsules

Dexa Medica

Ingredients in every capsule

Cefdinir 100 mg

Each package contains

1 strip of 10 capsules

Other details

Dosage form:Capsule; hard
Flavour: None

W.H.O. classification

ATC Level 1: J - Antiinfectives for systemic use
ATC Level 2: J01 - Antibacterials for Systemic Use
ATC Level 3: J01D - Other Beta-Lactam Antibacterials in ATC

Warnings

Pregnancy

CONSULT YOUR DOCTORSafety of this item for use during pregnancy has not been established. Please consult your doctor.

Lactation

NOT SAFEThis item is not safe for use during lactation.

Alcohol

CONSULT YOUR DOCTORSafety of this item for use with alcohol has not been established. Please consult your doctor.

Machinery

CAUTIONThis item may not be safe for use while operating heavy machinery. Use with caution.

Available in

Indonesia

Dosage information

12 YEARS OLD AND ABOVE
– Respiratory tract infections and other infections caused by susceptible Gram-positive bacteria: 3 x 100 mg/day (3 x 1 capsule/day).
– Severe infections caused by susceptible Gram-negative bacteria: 2 x 300 mg/day (3 capsules in the morning and 3 capsules in the evening).
– Uncomplicated urinary tract infections: 2 x 100 mg/day (1 capsule in the morning and 1 capsule in the evening).

0 TO 12 YEARS OLD
Safety has not been established

ADMINISTRATION
To minimize the appearance of organisms resistant to cefdinir, as a rule the susceptibility of causative organisms should be confirmed before use and administration should be limited to the shortest period that is needed for the treatment of the infection.

Indication

Cefdinir is indicated for the treatment of the following infections caused by susceptible strains of the designated microorganisms in the following diseases:
– Upper respiratory tract infections caused by Streptococcus pyogenes.
– Skin and skin structure infections caused by Staphylococcus aureus and Streptococcus pyogenes.
– Lower respiratory tract infections caused by Streptococcus pneumoniae and Haemophilus influenzae (β-lactamases positive and negative strains).
– Urinary tract infections caused by Escherichia coli and Proteus mirabilis.

Disclaimer

The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for informational purposes only. This tool may not cover all possible drug interactions or all warnings or alerts. Please check with a physician if you have health questions or concerns about interactions or go to the appropriate government authority for a comprehensive list of medical warnings. Although we attempt to provide accurate and up-to-date information, no guarantee is made to that effect.

All of the content present on this website, including written text, photographs, videos, graphics, and other resources we might include (these will fall under the collective term of “website”), is meant to educate and should not be perceived as a substitution for professional medical advice, diagnosis or treatment. You should not resort to the website information to arrive at a diagnosis or treatment solution for your health problems or various medical conditions. It does not replace medical care, provided by a medical specialist. In the situation, you have specific symptoms and you might suspect that you are suffering from a medical problem, it is for the best to consult your physician.